NEULASTA (PEGFILGRASTIM)

6 mg/0.6 mL with wearable subcutaneous injector

• Inject 0.6 milliliter (6 mg) by subcutaneous route once per chemotherapy cycle ;Do not use between 14 days before and 24 hours after chemo

6 mg/0.6 mL subcutaneous syringe

• Inject 0.6 milliliter (6 mg) by subcutaneous route once per chemotherapy cycle ;Do not use between 14 days before and 24 hours after chemo

Chemotherapy-induced neutropenia

• Inject 0.6 milliliter (6 mg) by subcutaneous route once per chemotherapy cycle ; do not administer in the period between 14 days before and24 hours after administration of chemotherapy

• Inject 0.6 milliliter (6 mg) by subcutaneous route once per chemotherapy cycle ;Do not use between 14 days before and 24 hours after chemo

Hematopoietic syndrome of acute radiation syndrome

• Inject 0.6 milliliter (6 mg) by subcutaneous route once followed by 0.6 ml (6 mg) 1 week after the first dose for a total of 2 doses

Prevention of neutropenia from cancer chemotherapy

• Inject 0.6 milliliter (6 mg) by subcutaneous route once per chemotherapy cycle ; do not administer in the period between 14 days before and24 hours after administration of chemotherapy

• Inject 0.6 milliliter (6 mg) by subcutaneous route once per chemotherapy cycle ;Do not use between 14 days before and 24 hours after chemo